Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04260009
Brief Title: Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid Tumors

First Submitted : January 22, 2020
First Submitted that Met QC Criteria : February 5, 2020
First Posted : February 7, 2020

Last Update Submitted that Met QC Criteria : March 2, 2020
Last Update Posted : March 5, 2020